ListarDAAPC-Artículos, capítulos... por tema "PARP inhibitors"

Mostrando ítems 1-1 de 1

    • New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? 

      Aurilio, Gaetano; Cimadamore, Alessia; Santoni, Matteo; Nolé, Franco; Scarpelli, Marina; Massari, Francesco; López-Beltrán, Antonio; Cheng, Liang; Montironi, Rodolfo (MDPI, 2020)
      Medical treatment for metastatic castration-resistant prostate cancer (mCRPC) patients has progressively been evolving from a nonspecific clinical approach to genomics-oriented therapies. The scientific community is in ...